Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty Acids (Membrane Disruption) (FA (Membrane Disruption))
- Target
- FA (Membrane Disruption)
- Molecular classification
- Lipid, Fatty Acid, Membrane Disruptor
01
Overview
Fatty acids with specific chain lengths and degrees of saturation can disrupt biological membranes, leading to increased permeability or pore formation. This property is exploited in antimicrobial activity and implicated in regulated cell death processes like necroptosis. The disruptive potential depends on the fatty acid’s structure, with very long chain fatty acids (VLCFAs) being particularly effective. This disruption affects membrane fluidity, protein function, and cellular signaling, linking it to various diseases.
- Other names
- Membrane-Disrupting Fatty AcidsLipid Bilayer Disruption by Fatty AcidsFatty Acid Membrane Permeabilizers
02
Mechanism of action
Direct bilayer permeabilization, pore formation, protein acylation leading to membrane destabilization and leakage of cellular contents
03
Biological functions
Membrane permeabilizationAntimicrobial activityRegulation of cell death (necroptosis)Alteration of membrane fluidityModulation of protein function within lipid bilayer
04
Disease associations
InfectionMetabolic diseases (e.g., diabetes)Cardiovascular diseaseInflammationCancer progressionNeurodegenerative disease
05
Safety considerations
Non-selective membrane disruption leading to cellular toxicityPotential for off-target effects on mammalian cell membranes
06
Interacting drugs
Antimicrobials (structure-specific fatty acids)
1 more in the full profile.
07
Biomarkers
VLCFA levels in necroptosisSpecific FA profiles in metabolic disorders
Beyond the preview
Go deeper on Fatty Acids (Membrane Disruption) (FA (Membrane Disruption)).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fatty Acids (Membrane Disruption) (FA (Membrane Disruption)).